HANHUI
Live / Registered — Registered (as of 28 Jun 2022)
What this means for you
Registered since 28 Jun 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79307453
- Registration number
- 6770020
- Mark type
- Stylized text
- Filed
- 30 Jan 2021
- Published for opposition
- 12 Apr 2022
- Registered
- 28 Jun 2022
- Attorney of record
- Christine P. James
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in chemotherapy, radiotherapy, endocrine therapy, anesthesia; Pharmaceutical preparations for supplementing vitamins and nutrition, namely, dietary and nutritional supplements; Pharmaceutical preparations for anti-infection and antiviral purposes; Pharmaceutical preparations for improving lactation functions; Pharmaceutical preparations for treating hematological diseases, namely, anemia, leucocyte disorders, blood clots; Pharmaceutical preparations for treating cardiovascular and cerebrovascular diseases, namely, blood lipid disorder, blood pressure disorder, arrhythmia, cardiac insufficiency, angina pectoris, myocardial infarction; Pharmaceutical preparations for treating respiratory system diseases, namely, phlegm, cough, asthma; Pharmaceutical preparations for treating digestive system diseases and disorders, namely, peptic ulcer, diarrhea; Pharmaceutical preparations for treating central nervous diseases and disorders, namely, fever and pain, gout, epilepsy, Parkinsonian syndrome, psychotic disorders, depression, anxiety, mania; Pharmaceutical preparations for treating geriatric diseases, namely, hyperosteogeny, prostatic hyperplasia, senile cataract; Pharmaceutical preparations for treating genitourinary system diseases, endocrine and metabolic system diseases and disorders, allergies, immune system diseases and disorders, liver and gall diseases, Alzheimer's diseases, skin diseases and disorders, obstetric and gynecological diseases and disorders, diseases with eye, ear, nose, mouth, oral cavity, and throat; Chemical preparations for pharmaceutical and medical purposes, namely, antineoplastic drugs, antibiotics, anti-infectives, vitamins and nutritional supplements, anesthetics, and those for treating hematological system diseases, cardiovascular and cerebrovascular diseases, endocrine and metabolic diseases and disorders, respiratory system diseases, digestive system diseases and disorders, central nervous system diseases and disorders, dermatological diseases, obstetric and gynecological diseases and disorders, ophthalmology and otorhinolaryngology diseases, and geriatric diseases; Analgesics; Medicines for humans, namely, antineoplastic drugs, anti-infectives, antibiotics, anesthetics, vitamin and nutritional supplements, and medicines for the treatment of allergy, cardiovascular and cerebrovascular diseases, dermatological diseases, geriatric diseases, and diseases with hematological system, genitourinary system, endocrine and metabolic system, immune system, respiratory system, digestive system, central nervous system, obstetrics and gynecology system, eye, ear, mouth, and throat; Sedatives; Tranquillizers; Biological preparations for medical purposes, namely, vaccines, antineoplastic preparations, antitoxin, and antisera; Antibiotics; Injectable pharmaceuticals, namely, antineoplastic drugs, anti-infectives, antibiotics, anesthetics, vitamin and nutritional supplements, and those for the treatment of allergy, cardiovascular and cerebrovascular diseases, dermatological diseases, geriatric diseases, ophthalmology and otorhinolaryngology diseases, and diseases with hematological system, genitourinary system, endocrine and metabolic system, immune system, respiratory system, digestive system, central nervous system, obstetrics and gynecology system; Tablets, namely, antineoplastic drugs, anti-infectives, antibiotics, anesthetics, vitamin and nutritional supplements, and tablets for the treatment of allergy, cardiovascular and cerebrovascular diseases, dermatological diseases, geriatric diseases, ophthalmology and otorhinolaryngology diseases, and diseases with hematological system, genitourinary system, endocrine and metabolic system, immune system, respiratory system, digestive system, central nervous system, obstetrics and gynecology system; Bulk medicines, namely, antineoplastic drugs, anti-infectives, antibiotics, anesthetics, vitamin and nutritional supplements, and medicines for the treatment of allergy, cardiovascular and cerebrovascular diseases, dermatological diseases, geriatric diseases, ophthalmology and otorhinolaryngology diseases, and diseases with hematological system, genitourinary system, endocrine and metabolic system, immune system, respiratory system, digestive system, central nervous system, obstetrics and gynecology system; Biochemical medicines, namely, antineoplastic drugs, anti-infectives, antibiotics, and medicines for the treatment of allergy, cardiovascular and cerebrovascular diseases, and diseases with hematological system, genitourinary system, endocrine and metabolic system, immune system, respiratory system, digestive system, and central nervous system; Blood for medical purposes; Herbal tinctures for medical purposes; Diagnostic preparations for medical purposes; Chemical reagents for medical or veterinary purposes; Radium for medical purposes; Radioactive substances for medical purposes; Isotopes for medical purposes; Radioactive medicines for medical imaging and the treatment of tumor and thyroid diseases; Oxygen for medical purposes; Chemical conductors for electrocardiograph electrodes; Semen for artificial insemination; Disinfectants for hygiene purposes; Disinfectants; Solutions for contact lenses; Contact lens cleaning preparations; Media for bacteriological cultures; Bouillons for bacteriological cultures; Bacteriological culture mediums; Nutritive substances for microorganisms for medical purposes; Cultures of microorganisms for medical and veterinary use; Disinfectant wipes; Wadding for medical purposes; Food for babies
Owner
Prosecution history
- 09 Apr 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 01 Nov 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 06 Oct 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 06 Oct 2022 — FINAL DISPOSITION PROCESSED
- 28 Sept 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 21 Aug 2022 — NEW REPRESENTATIVE AT IB RECEIVED
- 28 Jun 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Jun 2022 — REGISTERED-PRINCIPAL REGISTER
- 12 Apr 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Apr 2022 — PUBLISHED FOR OPPOSITION
- 23 Mar 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Mar 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Mar 2022 — EXAMINER'S AMENDMENT ENTERED
- 08 Mar 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 08 Mar 2022 — EXAMINERS AMENDMENT E-MAILED